SY-008

DRUG2 trials

Sponsors

Suzhou Yabao Pharmaceutical R&D Co., Ltd.

Conditions

DiabetesType 2 Diabetes Mellitus

Phase 1

Single Ascending Oral Doses of SY-008 in Healthy Subjects

CompletedNCT03462589

Suzhou Yabao Pharmaceutical R&D Co., Ltd.Diabetes

Start: 2018-08-02End: 2018-12-30Updated: 2019-10-10

Multiple Ascending Doses of SY-008 in Type 2 Diabetes Mellitus

CompletedNCT04345120

Suzhou Yabao Pharmaceutical R&D Co., Ltd.Type 2 Diabetes Mellitus

Start: 2020-06-15End: 2021-12-15Updated: 2022-05-18